User contributions

Jump to: navigation, search
Search for contributions
 
 
      
 
   

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

  • 12:31, 12 June 2019 (diff | hist) . . (-1,046)‎ . . DEC1 ‎
  • 09:19, 12 June 2019 (diff | hist) . . (-20)‎ . . DEC1 ‎
  • 09:17, 12 June 2019 (diff | hist) . . (+215)‎ . . DEC1 ‎
  • 09:10, 12 June 2019 (diff | hist) . . (+3,280)‎ . . N DEC1 ‎ (Created page with "''DEC1'', an antinsense transcript required for tumorogenicity of ovarian and colorectal cancer cells ==Annotated Information== ===Name=== ''DEC1': deleted in esophageal canc...")
  • 03:31, 26 December 2018 (diff | hist) . . (+2,966)‎ . . N LINC01703 ‎ (Created page with "''LINC01703'', regulates the expression of PARP1 and is a novel molecule involved in the progression of HCC ==Annotated Information== ===Approved Symbol=== ''LINC01703'' ===A...")
  • 03:10, 26 December 2018 (diff | hist) . . (+59)‎ . . ZSCAN2-DT ‎ (current)
  • 03:09, 26 December 2018 (diff | hist) . . (+42)‎ . . ZSCAN2-DT ‎ (→‎Approved Name)
  • 03:02, 26 December 2018 (diff | hist) . . (+1,486)‎ . . N ZSCAN2-DT ‎ (Created page with "''ZKSCAN2-DT'', ==Annotated Information== ===Approved Symbol=== ''ZKSCAN2-DT'' ===Approved Name=== ''ZKSCAN2-DT'': ===Characteristics=== ''ZKSCAN2-DT'' is a long noncoding...")
  • 02:45, 26 December 2018 (diff | hist) . . (+2,143)‎ . . N ZKSCAN7-AS1 ‎ (Created page with "''ZKSCAN7-AS1'', a set of biomarkers for the prognosis of patients with GBM,enabling a moreaccurate prediction of survival and revealingmorebiological functions. ==Annotated...")
  • 02:38, 26 December 2018 (diff | hist) . . (+2,497)‎ . . N LINC02601 ‎ (Created page with "''LINCO2601'', a set of biomarkers for the prognosis of patients with GBM,enabling a moreaccurate prediction of survival and revealingmorebiological functions. ==Annotated In...") (current)
  • 02:25, 26 December 2018 (diff | hist) . . (+2,107)‎ . . N ITGA6-AS1 ‎ (Created page with "''ITGA6-AS1'', a set of biomarkers for the prognosis of patients with GBM,enabling a moreaccurate prediction of survival and revealingmorebiological functions. ==Annotated In...")
  • 02:18, 26 December 2018 (diff | hist) . . (+17)‎ . . ACTR3-AS1 ‎ (→‎Sequence)
  • 02:18, 26 December 2018 (diff | hist) . . (+2,169)‎ . . N ACTR3-AS1 ‎ (Created page with "''ACTR3-AS1'', a set of biomarkers for the prognosis of patients with GBM,enabling a moreaccurate prediction of survival and revealingmorebiological functions. ==Annotated In...")
  • 07:06, 25 December 2018 (diff | hist) . . (+97)‎ . . MPPED2-AS1 ‎ (current)
  • 07:04, 25 December 2018 (diff | hist) . . (+6,384)‎ . . N MPPED2-AS1 ‎ (Created page with "''MPPED2-AS1'', and its associated gene MPPED2 are down-regulated in Human Thyroid Neoplasias and act as tumour suppressors ==Annotated Information== ===Approved Symbol=== '...")
  • 06:27, 24 December 2018 (diff | hist) . . (+68)‎ . . ARLNC1 ‎
  • 06:24, 24 December 2018 (diff | hist) . . (+4,417)‎ . . N ARLNC1 ‎ (Created page with "''ARLNC1'', plays an important role in prostate cancer progression ==Annotated Information== ===Approved Symbol=== ''ARLNC1'' ===Approved Name=== ''ARLNC1'': ===Characterist...")
  • 05:52, 24 December 2018 (diff | hist) . . (+3,136)‎ . . N LINC01121 ‎ (Created page with "''LINC01121'', Inhibits Cell Apoptosis While Facilitating Proliferation, Migration, and Invasion Though Negative Regulation of the Camp/PKA Signaling Pathway via GLP1R ==Anno...")
  • 03:15, 24 December 2018 (diff | hist) . . (+4,085)‎ . . N NGF-AS1 ‎ (Created page with "''NGF-AS1'', is a SNP containing long noncoding RNA associated with Dysmenorrhea. ==Annotated Information== ===Approved Symbol=== ''NGF-AS1'' ===Approved Name=== ''NGF-AS1'':...") (current)
  • 02:35, 24 December 2018 (diff | hist) . . (+8,320)‎ . . N NKAIN3-IT1 ‎ (Created page with "''NKAIN3-IT1'', is dysregulated in Glioblastoma. ==Annotated Information== ===Approved Symbol=== ''NKAIN3-IT1'' ===Approved Name=== ''NKAIN3-IT1'': NKAIN3 intronic transcript,...") (current)
  • 02:07, 24 December 2018 (diff | hist) . . (+3,352)‎ . . N LINC02244 ‎ (Created page with "''LINC02244'', attenuated adipogenesis of preadipocytes, which is conducive to the search for new diagnostic and therapeutic strategies of childhood obesity ==Annotated Inform...")
  • 08:32, 21 December 2018 (diff | hist) . . (+5,098)‎ . . N TNRC6C-AS1 ‎ (Created page with "''TNRC6C-AS1'', regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p ==Annotated Information...") (current)
  • 07:48, 21 December 2018 (diff | hist) . . (+8)‎ . . UGDH-AS1 ‎ (→‎Sequence) (current)
  • 07:48, 21 December 2018 (diff | hist) . . (+4,662)‎ . . N UGDH-AS1 ‎ (Created page with "''UGDH-AS1'', a long non-coding RNA linked to intervertebral disc degeneration. ==Annotated Information== ===Approved Symbol=== ''UGDH-AS1'' ===Approved Name=== ''UGDH-AS1'...")
  • 06:33, 21 December 2018 (diff | hist) . . (+3,898)‎ . . N TBILA ‎ (Created page with "''TBILA'', promotes non-small cell lung cancer progression in vitro and in vivo. ==Annotated Information== ===Approved Symbol=== ''TBILA'' ===Approved Name=== ''TBILA'': TGF...") (current)
  • 04:31, 21 December 2018 (diff | hist) . . (+2,012)‎ . . N LINC01060 ‎ (Created page with "''LINC01060'', induces pancreatic cancer progression through vinculin-mediated focal adhesion turnover ==Annotated Information== ===Approved Symbol=== ''LINC01060'' ===Approve...") (current)
  • 05:27, 18 December 2018 (diff | hist) . . (+1)‎ . . GPRACR ‎
  • 04:59, 18 December 2018 (diff | hist) . . (+5,043)‎ . . N GPRACR ‎ (Created page with "''GPRACR'',drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner. ==Annotated Information== ===Approved Symbol=== ''...")
  • 03:47, 18 December 2018 (diff | hist) . . (+1)‎ . . LINCADAL ‎ (→‎Sequence)
  • 03:46, 18 December 2018 (diff | hist) . . (+3,029)‎ . . N LINCADAL ‎ (Created page with "''LINCADL'', human subcutaneous adipose lincRNA associated with obesity ==Annotated Information== ===Approved Symbol=== ''LINCADL'' ===Approved Name=== ''LINCADL'': lincRNA a...")
  • 07:31, 17 December 2018 (diff | hist) . . (0)‎ . . GARS-DT ‎ (current)
  • 07:30, 17 December 2018 (diff | hist) . . (-49)‎ . . GARS-DT ‎
  • 07:29, 17 December 2018 (diff | hist) . . (+6,584)‎ . . N GARS-DT ‎ (Created page with "''GARS-DT'', A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction ==Annotated Information== ===Approved Symbol=...")
  • 04:24, 17 December 2018 (diff | hist) . . (+4,065)‎ . . N NKX2-1-AS1 ‎ (Created page with "''NKX2-1-AS1'', negatively regulates CD274/PD-L1, cell-cell interaction genes, and limits human lung carcinoma cell migration ==Annotated Information== ===Approved Symbol===...") (current)
  • 03:49, 17 December 2018 (diff | hist) . . (+2,550)‎ . . N DCXR-DT ‎ (Created page with "''DCXR-DT'', A long non-coding RNA that shows potent activity in prostate cancer. ==Annotated Information== ===Approved Symbol=== ''DCXR-DT'' ===Approved Name=== ''DCXR-DT'':...")
  • 06:30, 11 December 2018 (diff | hist) . . (+7)‎ . . LNCOG ‎ (→‎Sequence)
  • 06:30, 11 December 2018 (diff | hist) . . (+3,833)‎ . . N LNCOG ‎ (Created page with "''LNCOG'', Promotes the Osteogenic Differentiation of Bone Marrow‐Derived Mesenchymal Stem Cells ==Annotated Information== ===Approved Symbol=== ''LNCOG'' ===Approved Name=...")
  • 07:27, 10 December 2018 (diff | hist) . . (+5)‎ . . LncARSR ‎ (→‎References) (current)
  • 07:25, 10 December 2018 (diff | hist) . . (+10)‎ . . LNCAROD ‎ (→‎References)
  • 07:24, 10 December 2018 (diff | hist) . . (+3,478)‎ . . N LNCAROD ‎ (Created page with "''LNCAROD'', Long ncRNA activates its target gene DKK1 at its release from chromatin ==Annotated Information== ===Approved Symbol=== ''LNCAROD'' ===Approved Name=== ''LNCAROD'...")
  • 03:59, 10 December 2018 (diff | hist) . . (+14,327)‎ . . N SILC1 ‎ (Created page with "''SILC1'', influence the proliferation and apoptosis of neuroblastoma cells via the HIF-1a and p53 pathways ==Annotated Information== ===Approved Symbol=== ''SILC1'' ===Approv...") (current)
  • 06:23, 7 December 2018 (diff | hist) . . (+3,043)‎ . . LncARSR ‎
  • 04:47, 7 December 2018 (diff | hist) . . (+5,123)‎ . . N SCAT1 ‎ (Created page with "''SCAT1'', act as a independent prognostic factor. ==Annotated Information== ===Approved Symbol=== ''SCAT1'' ===Approved Name=== ''SCAT1'': S-phase cancer associated transcrip...") (current)
  • 02:28, 7 December 2018 (diff | hist) . . (+5,175)‎ . . N LINC00858 ‎ (Created page with "''LINC00858'', a competing endogenous RNA for miR-422a to facilitate the cell growth in non-small cell lung cancer. ==Annotated Information== ===Approved Symbol=== ''LINC008...")
  • 03:32, 6 December 2018 (diff | hist) . . (+4)‎ . . PICART1 ‎ (→‎Approved Name) (current)
  • 03:31, 6 December 2018 (diff | hist) . . (+175)‎ . . PICART1 ‎
  • 03:28, 6 December 2018 (diff | hist) . . (+4,843)‎ . . N PICART1 ‎ (Created page with "''PICART1'', a long noncoding RNA that mediates cancer cell proliferation and migration ==Annotated Information== ===Approved Symbol=== ''PICART1'' ===Approved Name=== ''PIC...")
  • 04:50, 23 November 2018 (diff | hist) . . (+1)‎ . . HSALNG0007045 ‎ (→‎Approved Name)
  • 04:49, 23 November 2018 (diff | hist) . . (-5)‎ . . HSALNG0007045 ‎
  • 04:48, 23 November 2018 (diff | hist) . . (+783)‎ . . HSALNG0007045 ‎

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php/Special:Contributions/Huma"